Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atea Pharmaceuticals, Inc.

2.84
-0.1200-4.05%
Volume:240.91K
Turnover:697.64K
Market Cap:242.89M
PE:-1.42
High:2.95
Open:2.91
Low:2.84
Close:2.96
Loading ...

the Radoff-Jec Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors

THOMSON REUTERS
·
26 Mar

Atea Pharmaceuticals issues statement regarding director nominations

TIPRANKS
·
22 Mar

BRIEF-Atea Pharmaceuticals receives notice of director nominations from Bradley Radoff

Reuters
·
22 Mar

Atea Pharmaceuticals: Bradley L. Radoff to Nominate Three Director Candidates to Stand for Election to Co's Board

THOMSON REUTERS
·
22 Mar

Atea Pharmaceuticals Inc - Receives Notice of Director Nominations From Bradley L. Radoff

THOMSON REUTERS
·
22 Mar

Press Release: Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Dow Jones
·
22 Mar

Atea Pharmaceuticals announces presentation of bemnifosbuvir preclinical data

TIPRANKS
·
19 Mar

Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential

Simply Wall St.
·
14 Mar

Atea Pharmaceuticals Faces Challenges Amid Workforce Reductions and Cost-Cutting Efforts

TIPRANKS
·
08 Mar

Atea Pharmaceuticals’ Promising Earnings Call Highlights

TIPRANKS
·
08 Mar

Q4 2024 Atea Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
08 Mar

Atea Pharmaceuticals Inc (AVIR) Q4 2024 Earnings Call Highlights: Strategic Moves and Promising ...

GuruFocus.com
·
07 Mar

Atea Pharmaceuticals Cuts Workforce by 25%

Dow Jones
·
07 Mar

Atea Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Mar

Atea Pharmaceuticals reports Q4 EPS (40c), consensus (29c)

TIPRANKS
·
07 Mar

Atea Pharmaceuticals Q4 EPS $(0.40) Misses $(0.37) Estimate

Benzinga
·
07 Mar

BRIEF-Atea Pharmaceuticals Q4 Basic EPS USD -0.4

Reuters
·
07 Mar

Atea Pharmaceuticals Inc - Reduces Workforce by Approximately 25% in Q1 2025

THOMSON REUTERS
·
07 Mar

Atea Pharmaceuticals Inc - Expects $15 Million Cost Savings Through 2027 From Workforce Reduction

THOMSON REUTERS
·
07 Mar

Atea Pharmaceuticals Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
05 Mar